Predicting the unpredictable

Transmission of drug-resistant HIV

S. M. Blower, A. N. Aschenbach, H. B. Gershengorn, J. O. Kahn

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

We use a mathematical model to understand (from 1996 to 2001) and to predict (from 2001 to 2005) the evolution of the epidemic of drug-resistant HIV in San Francisco. We predict the evolutionary trajectories for 1,000 different drug-resistant strains with each strain having a different fitness relative to a drug-sensitive strain. We calculate that the current prevalence of resistance is high, and predict it will continue to rise. In contrast, we calculate that transmission of resistance is currently low, and predict it will remain low. We show that the epidemic of resistance is being generated mainly by the conversion of drug-sensitive cases to drug-resistant cases, and not by the transmission of resistant strains. We also show that transmission of resistant strains has not increased the overall number of new HIV infections. Our results indicate that transmission of resistant strains is, and will remain, a relatively minor public health problem.

Original languageEnglish (US)
Pages (from-to)1016-1020
Number of pages5
JournalNature Medicine
Volume7
Issue number9
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

HIV
Pharmaceutical Preparations
San Francisco
Public health
Medical problems
HIV Infections
Theoretical Models
Public Health
Trajectories
Mathematical models

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Blower, S. M., Aschenbach, A. N., Gershengorn, H. B., & Kahn, J. O. (2001). Predicting the unpredictable: Transmission of drug-resistant HIV. Nature Medicine, 7(9), 1016-1020. https://doi.org/10.1038/nm0901-1016

Predicting the unpredictable : Transmission of drug-resistant HIV. / Blower, S. M.; Aschenbach, A. N.; Gershengorn, H. B.; Kahn, J. O.

In: Nature Medicine, Vol. 7, No. 9, 2001, p. 1016-1020.

Research output: Contribution to journalArticle

Blower, SM, Aschenbach, AN, Gershengorn, HB & Kahn, JO 2001, 'Predicting the unpredictable: Transmission of drug-resistant HIV', Nature Medicine, vol. 7, no. 9, pp. 1016-1020. https://doi.org/10.1038/nm0901-1016
Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO. Predicting the unpredictable: Transmission of drug-resistant HIV. Nature Medicine. 2001;7(9):1016-1020. https://doi.org/10.1038/nm0901-1016
Blower, S. M. ; Aschenbach, A. N. ; Gershengorn, H. B. ; Kahn, J. O. / Predicting the unpredictable : Transmission of drug-resistant HIV. In: Nature Medicine. 2001 ; Vol. 7, No. 9. pp. 1016-1020.
@article{12144e840ab14c8fba3ea8db2c80f71b,
title = "Predicting the unpredictable: Transmission of drug-resistant HIV",
abstract = "We use a mathematical model to understand (from 1996 to 2001) and to predict (from 2001 to 2005) the evolution of the epidemic of drug-resistant HIV in San Francisco. We predict the evolutionary trajectories for 1,000 different drug-resistant strains with each strain having a different fitness relative to a drug-sensitive strain. We calculate that the current prevalence of resistance is high, and predict it will continue to rise. In contrast, we calculate that transmission of resistance is currently low, and predict it will remain low. We show that the epidemic of resistance is being generated mainly by the conversion of drug-sensitive cases to drug-resistant cases, and not by the transmission of resistant strains. We also show that transmission of resistant strains has not increased the overall number of new HIV infections. Our results indicate that transmission of resistant strains is, and will remain, a relatively minor public health problem.",
author = "Blower, {S. M.} and Aschenbach, {A. N.} and Gershengorn, {H. B.} and Kahn, {J. O.}",
year = "2001",
doi = "10.1038/nm0901-1016",
language = "English (US)",
volume = "7",
pages = "1016--1020",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Predicting the unpredictable

T2 - Transmission of drug-resistant HIV

AU - Blower, S. M.

AU - Aschenbach, A. N.

AU - Gershengorn, H. B.

AU - Kahn, J. O.

PY - 2001

Y1 - 2001

N2 - We use a mathematical model to understand (from 1996 to 2001) and to predict (from 2001 to 2005) the evolution of the epidemic of drug-resistant HIV in San Francisco. We predict the evolutionary trajectories for 1,000 different drug-resistant strains with each strain having a different fitness relative to a drug-sensitive strain. We calculate that the current prevalence of resistance is high, and predict it will continue to rise. In contrast, we calculate that transmission of resistance is currently low, and predict it will remain low. We show that the epidemic of resistance is being generated mainly by the conversion of drug-sensitive cases to drug-resistant cases, and not by the transmission of resistant strains. We also show that transmission of resistant strains has not increased the overall number of new HIV infections. Our results indicate that transmission of resistant strains is, and will remain, a relatively minor public health problem.

AB - We use a mathematical model to understand (from 1996 to 2001) and to predict (from 2001 to 2005) the evolution of the epidemic of drug-resistant HIV in San Francisco. We predict the evolutionary trajectories for 1,000 different drug-resistant strains with each strain having a different fitness relative to a drug-sensitive strain. We calculate that the current prevalence of resistance is high, and predict it will continue to rise. In contrast, we calculate that transmission of resistance is currently low, and predict it will remain low. We show that the epidemic of resistance is being generated mainly by the conversion of drug-sensitive cases to drug-resistant cases, and not by the transmission of resistant strains. We also show that transmission of resistant strains has not increased the overall number of new HIV infections. Our results indicate that transmission of resistant strains is, and will remain, a relatively minor public health problem.

UR - http://www.scopus.com/inward/record.url?scp=0034785773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034785773&partnerID=8YFLogxK

U2 - 10.1038/nm0901-1016

DO - 10.1038/nm0901-1016

M3 - Article

VL - 7

SP - 1016

EP - 1020

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -